DNA

CORRECTION – OraQuick® HIV Self-Test Now Approved for Use in Adolescents

BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th…

1 year ago

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

CUPERTINO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage…

1 year ago

Korro to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on…

1 year ago

Erisyon Awarded $2.2M Grant to Develop Diagnostic for Immuno-Oncology Treatment Selection

AUSTIN, Texas, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Erisyon, a leading provider of single-molecule proteomics technology, today announced that it…

1 year ago

New England Biolabs® Launches EM-seq™ v2, an updated kit for more sensitive detection of 5mC and 5hmC

This bisulfite-free method of methylation detection is updated with a faster, more streamlined workflow that enables highly sensitive methylation analysis…

1 year ago

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

JUPITER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI),…

1 year ago

Rakovina Therapeutics Announces Receipt of AI-Derived Drug Candidates and Advancement to Preclinical Validation

VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company focused on the…

1 year ago

Avenues Announces Ribbon-Cutting and Open House of New South Bend Facility

SOUTH BEND, INDIANA / ACCESSWIRE / January 2, 2025 / Avenues Recovery Center announced today the ribbon-cutting ceremony and open…

1 year ago

GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing

Company today announced a major strategic step forward as it explores new growth avenuesArtificial Intelligence (AI) and Quantum Computing industries…

1 year ago

Making Cancer Drugs Safer: CellMosaic CEO to Host Live Investment Webinar

DoD-recognized biotech company opens investment round as its cancer treatment technology gains traction with 159+ global organizations. Woburn, MA, Dec.…

1 year ago